SCHEMBL8957419

SCHEMBL8957419

O=[N+]([O-])OCCC1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CHRM2 P08172 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
NFKB1 P19838 1/20 0.45
CHRM3 P20309 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2C P28335 1/20 0.45
ADRA1A P35348 1/20 0.45
HRH1 P35367 1/20 0.45
DRD3 P35462 1/20 0.45
THPO P40225 1/20 0.45
OPRK1 P41145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL9874960 0.77 HTR2A (0.46) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL11377253 0.70 HTR2A (0.49) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL8256345 0.69 HTR2A (0.69) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL9874718 0.69 HTR2A (0.57) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL11721748 0.67 HTR2A (0.57) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL3874745 0.66 HTR2A (0.61) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL11430690 0.66 HTR2A (0.61) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL11726371 0.66 HTR2A (0.64) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL11838306 0.65 HTR2A (0.80) HTR2AKDM4ELMNATP53CHRM2
SCHEMBL13393720 0.64 HTR2A (0.49) HTR2AKDM4ELMNATP53CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed